The CXCL12/CXCR4 axis confers temozolomide resistance to human glioblastoma cells via up-regulation of FOXM1

Apr 26, 2020Journal of the neurological sciences

The CXCL12/CXCR4 pathway may cause resistance to temozolomide in human glioblastoma cells by increasing FOXM1 levels

AI simplified

Abstract

The CXCL12/CXCR4 axis enhances temozolomide resistance in glioblastoma cells.

  • CXCL12/CXCR4 is associated with increased drug resistance in glioblastoma multiforme (GBM).
  • This axis promotes cell migration and invasion in GBM cells.
  • FOXM1 is up-regulated by CXCL12/CXCR4, contributing to TMZ resistance.
  • Suppressing CXCL12/CXCR4 and silencing FOXM1 partially reverses drug resistance.

AI simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free